|
|
Build Your Online Product Catalogs?
| Product Name: |
H3K4ME1
|
| Supply Ability: |
|
| Related proudcts |
histone h4, |
| Specifications |
1 |
| Price Term: |
|
| Port of loading: |
|
| Minimum Order |
|
| Unit Price: |
|
|
Synthesized histone H3 peptide corresponding to residues within 1-135 of human histone H3 with monomethylation K4 modification.
SPECIFICATION OF H3K4ME1
CAT H3101
Product Name Histone H3-K4me1
Purity ¡Ý95% by HPLC analysis
Appearance White powder
Usage Research use only
Storage Shipping at room temperature.
Upon delivery aliquot.
Stored at -20℃ or -80℃.
Avoid freeze/thaw cycle.
Sequence ARTK(me1)QTARKS TGGKAPRKQL ATKAARKSAP ATGGVKKPHR YRPGTVALRE IRRYQKSTEL LIRKLPFQRL VREIAQDFKT DLRFQSSAVM ALQEACEAYL VGLFEDTNLC AIHAKRVTIM PKDIQLARRI RGERA
APPLICATION OF H3K4ME1
H3K4me1 enhancer is an epigenetic modification to the DNA packaging Histone H3 protein. It is a mark that indicates the mono-methylation at the 4th lysine residue of the histone H3 protein and is often associated with gene enhancers. H3K4me1 is enriched at active and primed enhancers. Transcriptional enhancers control the cell-identity gene expression and are important in cell identity. Enhancers are primed by histone H3K4 mono-/di-methyltransferase MLL4 and then are activated by histone H3K27 acetyltransferase p300. H3K4me1 fine-tunes the enhancer activity and function rather than controls. H3K4me1 is put down by KMT2C (MLL3) and KMT2D (MLL4). ***1 and the related ***2/KDM1B demethylate H3K4me1 and H3K4me2. Marks associated with active gene transcription like H3K4me1 and H3K9me1 have very short half-lives.H3K4me1 with MLL3/4 can also act at promoters and repress genes.
There are many peptide pharmaceutical co***nies, but we are one of the best choices for you. |
| Company: |
Hefei KS-V Peptide Biological Technology Co., Ltd.
|
| Contact: |
KS-V Peptide .com |
| Address: |
The 11th floor£¬New Energy Building£¬Institute of Advanced Technology£¬USTC£¬Hefei, Anhui, China |
| Postcode: |
2018 |
| Tel: |
0551-65120828 |
| Fax: |
|
| E-mail: |
|
|
|
|
Home
